Pulse Biosciences (PLSE) Shares Outstanding (Weighted Average) (2015 - 2025)

Pulse Biosciences has reported Shares Outstanding (Weighted Average) for 11 years, with the latest figure at $67.4 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 2148.78% year-over-year to $67.4 million; the trailing twelve-month figure through Dec 2025 stood at $67.4 million (up 2148.78% YoY), and the FY2025 full-year result was $67.4 million, up 2148.78% from the prior year.
• Shares Outstanding (Weighted Average) for Q4 2025 stood at $67.4 million, roughly flat from $67.3 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $67.4 million in Q4 2025, with the low at $288490.0 in Q3 2021.
• Average Shares Outstanding (Weighted Average) over 5 years is $34.3 million, with a median of $29.7 million recorded in 2022.
• Year-over-year, Shares Outstanding (Weighted Average) soared 2434.05% in 2022 and sank 93.97% in 2024.
• Tracing PLSE's Shares Outstanding (Weighted Average) over 5 years: stood at $28.0 million in 2021, then tumbled by 73.88% to $7.3 million in 2022, then jumped by 580.97% to $49.7 million in 2023, then slumped by 93.97% to $3.0 million in 2024, then soared by 2148.78% to $67.4 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $67.4 million (Q4 2025), $67.3 million (Q3 2025), and $3.0 million (Q4 2024), per Business Quant data.

Peer Comparison